Clinical Trial Update: Dupilumab Skin Barrier Function Study in Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update shows completed study evaluating dupilumab's effect on skin barrier function in atopic dermatitis, with results posted in July 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Dupilumab (Dupixent) (Dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2022-07-22